Source: Annual Congress 2013 –Asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Selivanova, E. Kulikov, N. Kirillova, O. Kozina, M. Freidin, L. Ogorodova, S. Fedosenko (Tomsk, Petropavlovsk-Kamchatsk, Russian Federation). Nitric oxide oxidation products in bronchoalveolar lavage of patients with different severity of asthma. Eur Respir J 2013; 42: Suppl. 57, 860

Member's Comments

No comment yet.

Related content which might interest you: Bronchial and alveolar nitric oxide levels in healthy volunteers and patients with severe asthma Source: International Congress 2016 – Airway biomarkers Year: 2016 Inflammatory patterns in asthmatic children based on the measurement of alveolar nitric oxide Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 Alveolar nitric oxide and its role in asthma control assessment Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 Exhaled nitric oxide in asthma Source: Eur Respir Monogr 2010; 49: 32-44 Year: 2010 The levels of exhaled nitric oxide in controlled asthmatic patients with and without rhinitis Source: International Congress 2016 – Airway biomarkers Year: 2016 Relation of asthma control and exhaled nitric oxide in patients with bronchial hyperresponsiveness to methacholine Source: Annual Congress 2013 –New issues in lung function testing Year: 2013 Measurement of exhaled nitric oxide in patients with pulmonary tuberculosis Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013 Exhaled nitric oxide variations during oral challenge with different NSAIDs in patients with aspirin-induced asthma Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding Year: 2016 iNOS expression is increased in peripheral airways of asthmatic patients Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Elevated levels of alveolar nitric oxide in patients with inflammatory bowel disease Source: International Congress 2016 – Airway biomarkers Year: 2016 Utility of fractional exhaled nitric oxide (FeNO) in assessing asthma control following inhaled corticosteroid treatment Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Differences in exhaled nitric oxide levels between patients with cystic fibrosis and atopic bronchial asthma Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013 Role of fractional exhaled nitric oxide(FeNO) in obstructive airway diseases in Indian population Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Different patterns of exhaled NO response to acute bronchodilation in asthma Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 The effect of bronchodilation and spirometry on exhaled nitric oxide Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques Year: 2016 Exhaled nitric oxide in infants: a marker of inflammation? Source: Eur Respir Monogr 2010; 49: 56-70 Year: 2010 Features of production nitric oxide at patients with a bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 445s Year: 2006 Exhaled nitric oxide reference values in healthy Tunisian adults Source: Annual Congress 2013 –Various issues in clinical respiratory physiology Year: 2013 Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) to monitor asthma control Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 Fractional exhaled nitric oxide levels in patients with non-cystic fibrosis bronchiectasis Source: International Congress 2016 – Asthma, bronchiectasis, and the risk factors for respiratory morbidity Year: 2016